The increased IL-17A production by γδ T cells in the blood was retained over a period of 16 weeks of SSD-feeding (Fig. 8a), indicating that it is a potential marker for metabolic stress in the liver in context of NASH. Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.